Co., Ltd. ("Fosun Pharma" or "the Group"; SSE: 600196, HKEX: 02196), a leading innovation-driven global healthcare company, announced its financial results for the first three quarters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback